Nippon India Pharma Fund-Growth Plan-Growth Option

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 538.6435 ↓ -0.85%
[as on 14 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 14 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option 5.78% -0.85% -3.03% -5.06% -4.6% 5.6% 15.41% 11.56% 21.28% 14.07%
Nippon India Banking & Financial Services Fund-Growth Plan-Growth Option -7.44% -0.91% -0.27% -4.16% -6.5% -3.48% 9.6% 10.22% 13.42% 11.95%
Nippon India Power & Infra Fund-Growth Plan -Growth Option 5.18% 0.29% -0.6% -3.08% -3.3% 5.47% 15.53% 17.6% 21.79% 16.63%
DSP Healthcare Fund - Regular Plan - Growth 12.37% 0.2% -1.45% -2.67% -0.61% 12.6% 18.56% 13.64% 24.02%-
DSP Banking & Financial Services Fund - Regular - Growth -1.8% -1.33% -0.49% -5.8% -5.32% 3.69%----
BANDHAN Infrastructure Fund - Regular Plan - Growth -3% 0.51% -1.2% -3.09% -6.56% -5.11% 12.41% 13.83% 19.26% 14.1%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -10.27% 7.14% 3.79% 2.14% 67.04% 22.66% -10% 40.12% 34.25% -3.81%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.31% -4.73% 5.23% -4.93% 5.96% 2.29% 5.39% 2.64% 1.99% -2.74%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 11.69% 1.64%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.99% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.01%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.37%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology7.00%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.43%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.09%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.15%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.93%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology4.09%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.94%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.47%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology3.31%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services2.92%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.84%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.68%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing2.51%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.45%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology2.44%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology2.25%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.13%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.04%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology1.82%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.66%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology1.63%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.57%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.48%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.39%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.29%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.25%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.20%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology1.11%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.09%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology0.99%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology0.93%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.47%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.46%
Molbio Diagnostics Limited (INE869T01028)Healthcare Equipment & Supplies0.44%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.17%
Portfolio data is as on date 31 August, 2026

NAV history

Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
14 October, 2026538.6435 -0.85%
13 October, 2026543.2878 -0.05%
12 October, 2026543.5650 0.06%
9 October, 2026543.2215 0.35%
8 October, 2026541.3305 -2.55%
7 October, 2026555.4888 -0.37%
6 October, 2026557.5548 1.03%
5 October, 2026551.8837 -1.14%
1 October, 2026558.2323 -0.29%
30 September, 2026559.8525 -1.69%
29 September, 2026569.4618 0.23%
28 September, 2026568.1359 -0.81%
25 September, 2026572.7710 -0.36%
24 September, 2026574.8491 -0.55%
23 September, 2026578.0566 0.62%
22 September, 2026574.4885 -0.43%
21 September, 2026576.9669 0.87%
18 September, 2026572.0189 0.87%
17 September, 2026567.0911 1.21%
16 September, 2026560.3027 -0.26%
15 September, 2026561.7853 -0.98%
11 September, 2026567.3404 -0.22%
10 September, 2026568.6008 -0.57%
9 September, 2026571.8441 -0.34%
8 September, 2026573.7884 0.31%
7 September, 2026572.0413 0.23%
4 September, 2026570.7371 -0.57%
3 September, 2026574.0326 -0.17%
2 September, 2026575.0147 -0.11%
1 September, 2026575.6506

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 538.6435 as on 14 October, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 5.78% as on 14 October, 2026.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 5.6% as on 14 October, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 15.41% as on 14 October, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 11.56% as on 14 October, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 11.56% as on 14 October, 2026.
  • What are top 10 holdings of Nippon India Pharma Fund-Growth Plan-Growth Option?
    Top 10 holdings of Nippon India Pharma Fund-Growth Plan-Growth Option are:
    • Sun Pharmaceutical Industries Limited
    • Divi's Laboratories Limited
    • Lupin Limited
    • Cipla Limited
    • Apollo Hospitals Enterprise Limited
    • Dr. Reddy's Laboratories Limited
    • Mankind Pharma Limited
    • Sai Life Sciences Limited
    • Ajanta Pharma Limited
    • GlaxoSmithKline Pharmaceuticals Limited
    • Max Healthcare Institute Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Nippon India Pharma Fund-Growth Plan-Growth Option?
    Nippon India Pharma Fund-Growth Plan-Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.